On September 10, 2020, Rexahn Pharmaceuticals, Inc. (the "Company") reported that entered into Warrant Exchange Agreements (the "Agreements") with each of Empery Asset Master, Ltd. ("EAM"), Empery Tax Efficient, LP ("ETE") and Empery Tax Efficient II, LP ("ETE II" and together with EAM and ETE, the "Empery Entities") (Filing, 8-K, Rexahn, SEP 10, 2020, View Source [SID1234565015]). The Company previously issued to the Empery Entities (a) warrants to purchase an aggregate of 104,168 shares (on a post-reverse stock split basis) of its common stock, par value $.0001 per share (the "Common Stock") pursuant to the offering described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on November 6, 2015 (the "2015 Warrants"), (b) warrants to purchase an aggregate of 27,212 shares (on a post-reverse stock split basis) of Common Stock pursuant to the offering described in the Company’s Current Report on Form 8-K filed with the SEC on October 13, 2017 (the "2017 Warrants"), and (c) warrants to purchase an aggregate of 83,335 shares (on a post-reverse stock split basis) of Common Stock pursuant to the offering described in the Company’s Current Report on Form 8-K filed with the SEC on January 25, 2019 (the "2019 Warrants" and together with the 2015 Warrants and the 2017 Warrants, the "Warrants"). Pursuant to the Agreements, on September 10, 2020, the Company issued an aggregate of 16,324, 9,081 and 30,774 shares of Common Stock to EAM, ETE and ETE II, respectively, in exchange for the surrender and cancellation of the Warrants held by such holder.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!